Varespladib

DRUG2 trials

Sponsors

Anthera Pharmaceuticals, Ophirex, Inc.

Conditions

Coronavirus Disease 2019Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2Sickle Cell DiseaseVaso-occlusive Crisis

Phase 2

A Study of Varespladib Infusion in Subjects With Sickle Cell Disease.

TerminatedNCT01522196

Anthera PharmaceuticalsSickle Cell Disease, Vaso-occlusive Crisis

Start: 2012-02-29End: 2012-03-31Updated: 2014-03-04

Study of Varespladib in Patients Hospitalized With Severe COVID-19

TerminatedNCT04969991

Ophirex, Inc.Coronavirus Disease 2019, Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2

Start: 2021-06-30End: 2022-11-22Updated: 2025-05-15